North America Tissue Diagnostics Market Research Report - Segmented By Application, Product Type, End-User, Disease & Country (the U.S., Canada and Rest of North America) - Industry Analysis, Size, Share, Trends and Growth Forecast (2022 to 2027)
North America Tissue Diagnostics Market Size (2022 to 2027)
The size of the Tissue Diagnostics Market in North America is estimated at USD 1.36 billion in 2022. It is estimated to be growing at a CAGR of 6.6% to reach USD 1.88 billion by 2027. Increasing adoption of personalized medicine, substantial funds, and investments for R & D are significantly contributing to the market's growth.
Growth in the IVD’s, increasing aging population and rising death rate of cancer, and accelerating healthcare expenditure are majorly boosting the tissue diagnostics market in North America. Creating awareness in people to motivate initial diagnosis and monitoring are significant steps for early identification of cancer and is expected to favor the market growth. Developing infrastructure for cancer diagnosis and availability of reimbursement scenarios are a big plus to the growth rate of the market during the forecast timespan.
Restraints such as financial constraints and a high degree of consolidation are likely to hamper the market growth. Moreover, the high cost involving the deployment and high perforation is to inhibit the market growth.
Covid-19 is spreading all over the world very rapidly, creating a critical impact on the economy. The tissue diagnostics market is affected positively by the COVID-19. These tissue diagnostics find utilization in identifying the presence of the virus among the patients.
This research report on the North America Tissue Diagnostics Market has been segmented and sub-segmented into the following categories:
By Product Type:
- Instruments
- Microscope
- Non-contact Handheld IR Thermometer
- Haemocytometer
- NMR Tube
- Others
- Consumables
- Reagent kits
- Others
By Disease:
- Lung Cancer
- Lymphoma
- Pancreatic Cancer
- Breast Cancer
- Others
By Application:
- Immunohistochemistry
- Hematoxylin and Eosin
- In-Situ Hybridization
By End User:
- Contract Research Organizations
- Hospitals
- Diagnostic Laboratories
- Research Organizations
- Biotechnology Companies
By Country:
- The U.S.
- Canada
- Rest of North America
Regionally, the Tissue diagnostics market was dominated by North America due to the prevalence of cancer and health literacy supported by modern diagnostic techniques available.
The U.S. is leading the North American market in terms of revenue and growing R&D activities to develop diagnostics. Y-O-Y growth in cancer patients, developing healthcare infrastructure, enhanced insurance coverage, and reimbursement policies, which surge up the market growth in this region.
The Canadian market is the second leading country in the North American market and is expected to grow at a healthy CAGR during the forecast period. Increasing death cases, rising support from government and other private organizations, and critical players bolster the market. Moreover, the healthcare expenses are more in this country, where the country has spent nearly 253.5 billion USD for healthcare and is predicted to rise due to healthcare reforms and government policies. The government pays almost 70% of the healthcare cost for ease of diagnosis and treatment.
Companies playing a dominant role in the North America Tissue diagnostics Market profiled in this report are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology, and Ventana Medical Systems.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product type
5.1.1 Introduction
5.1.2 Instruments
5.1.2.1 Microscope
5.1.2.2 Non-contact Handheld IR Thermometer
5.1.2.3 Haemocytometer
5.1.2.4 NMR Tube
5.1.2.5 Others
5.1.3 Consumables
5.1.3.1 Reagent kits
5.1.3.2 Others
5.1.4 Y-o-Y Growth Analysis, By Product type
5.1.5 Market Attractiveness Analysis, By Product type
5.1.6 Market Share Analysis, By Product type
5.2 Disease
5.2.1 Introduction
5.2.2 Lung cancer
5.2.3 Lymphoma
5.2.4 Pancreatic cancer
5.2.5 Breast cancer
5.2.6 Others
5.2.7 Y-o-Y Growth Analysis, By Disease
5.2.8 Market Attractiveness Analysis, By Disease
5.2.9 Market Share Analysis, By Disease
5.3 Application
5.3.1 Introduction
5.3.2 Hematoxylin and Eosin
5.3.3 Immunohistochemistry
5.3.4 In Situ Hybridization
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End user
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Diagnostic laboratories
5.4.4 Research Organizations
5.4.5 Contract Research Organizations
5.4.6 Biotechnology Companies
5.4.7 Y-o-Y Growth Analysis, By End user
5.4.8 Market Attractiveness Analysis, By End user
5.4.9 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product type
6.1.3.3 By Disease
6.1.3.4 By Application
6.1.3.5 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product type
6.1.4.3 By disease
6.1.4.4 By Application
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product type
6.1.5.3 By Disease
6.1.5.4 By Application
6.1.5.5 By End user
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 F. Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Sigma-Aldrich Co. LLC
8.3 Abbott Laboratories
8.4 Agilent Technologies
8.5 BioGenex
8.6 Danaher Corporation
8.7 Cell Signaling Technology
8.8 Ventana Medical Systems
- North America Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
- North America Instruments Market, By Region, From 2022 - 2027 (USD Million)
- North America Consumables Market, By Region, From 2022 - 2027 (USD Million)
- North America Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
- North America Lung cancer Market, By Region, From 2022 - 2027 (USD Million)
- North America Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
- North America Pancreatic cancer Market, By Region, From 2022 - 2027 (USD Million)
- North America Breast cancer Market, By Region, From 2022 - 2027 (USD Million)
- North America Others Market, By Region, From 2022 - 2027 (USD Million)
- North America Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
- North America Hematoxylin and Eosin Market, By Region, From 2022 - 2027 (USD Million)
- North America Immunohistochemistry Market, By Region, From 2022 - 2027 (USD Million)
- North America In Situ Hybridization Market, By Region, From 2022 - 2027 (USD Million)
- North America Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
- North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
- North America Diagnostic laboratories Market, By Region, From 2022 - 2027 (USD Million)
- North America Research Organizations Market, By Region, From 2022 - 2027 (USD Million)
- North America Contract Research Organizations Market, By Region, From 2022 - 2027 (USD Million)
- North America Biotechnology Companies Market, By Region, From 2022 - 2027 (USD Million)
- United States Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
- United States Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
- United States Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
- United States Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
- Canada Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
- Canada Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
- Canada Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
- Canada Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
- North America Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
- North America Microscope Market, By Region, From 2022 - 2027 (USD Million)
- North America Non-contact Handheld IR Thermometer Market, By Region, From 2022 - 2027 (USD Million)
- North America Haemocytometer Market, By Region, From 2022 - 2027 (USD Million)
- North America NMR Tube Market, By Region, From 2022 - 2027 (USD Million)
- North America Others Market, By Region, From 2022 - 2027 (USD Million)
- United States Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
- Canada Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
Related Reports
ASK FOR CUSTOMIZATION
Talk to our analyst and get customised report done according to your research needs
INQUIRE FOR DISCOUNT
Check if you can avail any discount. Submit your details and our team will get back to you.
DOWNLOAD FREE SAMPLE
Request to avail a free sample report that reflects this market and its growth.
